Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study
Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study have?
Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study has 174 citations in the OpenAlex counts ScholarIQ stores.
When was Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study published?
Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study has 2019 year in the ScholarIQ index.
What is the open-access status of Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study?
Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study has hybrid oa status in the ScholarIQ index.
What is the DOI of Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study?
The DOI for Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study is on the source record.
What is the PMID of Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study?
The PMID for Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study is on the source record.
What is the OpenAlex record for Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study?
The OpenAlex for Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study is on the source record.